Clinical Trial Update: Changes in the Immune Response and Skin Reactivity of Grass Pollen Allergic Patients Treated With ALK Grass Tablets [Phase 3]

View source ↗

Summary

Phase 3 study evaluating ALK Grass Tablets in grass pollen allergic patients, focusing on changes in immune response and skin reactivity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Grass Pollen Allergy

Drugs mentioned

• ALK Grass Tablets

Snippet

Sponsor: ALK-Abelló A/S | Conditions: Allergy | Phase 3 | Status: COMPLETED